[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Pages 14941-14942]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05262]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of

[[Page 14942]]

the Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, CDC, pursuant to Public Law 92-463. The grant 
applications and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--GH16-003, Conducting Public 
Health Research in Thailand: technical collaboration with the Ministry 
of Public Health in the Kingdom of Thailand (MOPH); GH19-003, Advancing 
Infectious Disease Detection and Response in Senegal; GH19-005, 
Advancing Public Health Research in Bangladesh; GH19-006, Advancing 
Infectious Disease Detection and Response in Indonesia; GH19-008, Acute 
Febrile Illness in Uganda; GH19-009, Advancing Infectious Disease 
Detection and Response in Viet Nam; and GH19-010, Advancing Disease 
Detection and Response in Nigeria.
    Date: April 21, 2020
    Time: 9:00 a.m.--2:00 p.m., EDT
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Hylan Shoob, Ph.D., Scientific 
Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, 
Atlanta, Georgia 30329-4027, Telephone (404) 639-4796; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05262 Filed 3-13-20; 8:45 am]
 BILLING CODE 4163-18-P